1-(2,6-Dichlorophenyl)-2-indolinone CAS 15307-86-5

Product Description:

Product Name: 1-(2,6-Dichlorophenyl)-2-indolinone CAS NO: 15307-86-5

Synonyms:

2-(2-((2,6-dichlorophenyl)amino)phenyl)acetic acid;

2-[[2,6-Dichlorophenyl]amino]benzeneacetic acid;

Diclofena-c acid;

Chemical & Physical Properties:

Appearance: White to yellowish crystalline powder

Assay :≥99.0%

Density: 1.431 g/cm3

Boiling Point: 412℃ at 760 mmHg

Melting Point: 156-158℃

Flash Point: 203℃

Refractive Index: 1.66

Vapor Pressure: 1.07E-09mmHg at 25℃

Water Solubility: 1.278mg/L(30℃)

Safety Information:

Hazard Class: 6.1(b)

HS Code: 2942000000

Packing Group: III

Diclofena-c (sold under a number of trade names) is a nonsteroidal anti-inflammatory drug (NSAID) taken or applied to reduce inflammation and as an analgesic reducing pain in certain conditions. It is supplied as or contained in medications under a variety of trade names.

The name "diclofena-c" derives from its chemical name: 2-(2,6-dichloranilino) phenylace-tic acid. Diclofena-c was first synthesized by Alfred Sallmann and Rudolf Pfister and introduced as Voltaren by Ciba-Geigy (now Novartis) in 1973.

In the United Kingdom, United States, India, and Brazil diclofena-c may be supplied as either the sodium or potassium salt; in China, it is most often supplied as the sodium salt, while in some other countries it is only available as the potassium salt. It is available as a generic drug in a number of formulations, including diclofena-c diethylamine, which is applied topically. Over-the-counter (OTC) use is approved in some countries for minor aches and pains and fever associated with common infections. As of 2015 the cost for a typical month of medication in the United States is 50 to 100 USD.

The drug's use in animals is controversial due to its toxicity which can rapidly kill scavenging birds that may eat dead animals. It has been banned for veterinary use in many countries.

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.